Need for a primary care–based intervention for fear
of cancer recurrence: conclusions from the
BLANKET trial

With improved cancer treatments, the number of cancer survivors and the number of people facing challenges during cancer survivorship are increasing.[1] Over half of cancer survivors experience fear of cancer recurrence (FCR),[2] which has been labeled their most important unmet need.[3,4] FCR can lead to decreased quality of life[5] and increased health care costs,[6] and for most people, FCR does not dissolve over time without intervention.[7]